Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PainChek Ltd ( (AU:PCK) ) has shared an announcement.
PainChek Ltd has entered into a reseller and integration agreement with Eldermark Software LLC to expand its reach in the US long-term care market. This partnership will integrate PainChek’s AI-powered pain assessment tools into Eldermark’s care management systems, aiming to improve pain management accuracy and enhance resident care. The collaboration is a strategic move for PainChek as it anticipates FDA clearance, potentially impacting its market positioning and offering significant benefits to stakeholders in the care sector.
More about PainChek Ltd
PainChek Ltd is a company that develops smartphone-based pain assessment and monitoring applications. Their primary product is a regulatory-cleared medical device that enables best-practice pain management for individuals who cannot reliably self-report their pain. The company operates globally, with regulatory clearance in multiple regions including Australia, Canada, the European Union, and others, and is currently seeking FDA clearance in the United States.
Average Trading Volume: 1,241,599
Technical Sentiment Signal: Buy
Current Market Cap: A$90.25M
See more insights into PCK stock on TipRanks’ Stock Analysis page.